UCSF Cancer Research Institute received NCI Comprehensive Cancer Center designation
In 1999, University of California at San Francisco Cancer Research Institute received NCI Comprehensive Cancer Center designation. The…
Samuel N. Stroum was awarded E. Donnall Thomas Medal of Achievement Medal
In 1999, the Fred Hutchinson Business Alliance announced that the 1999 E. Donnall Thomas Medal of Achievement would…
Trubion Pharmaceutical was founded
In 1999, Trubion Pharmaceutical was founded in Seattle as a spin-off from the Pacific Northwest Diabetes Research Institute,…
Mouse model of prostate cancer was developed at Washington University – St Louis
On Dec. 22, 1998, Washington University – St. Louis researcher Jeffrey I. Gordon, MD and colleagues developed a…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Oncology | Therapeutics | Women's Health
The FDA approved the monoclonal antibody Herceptin (Trastuzumab) for treatment of metastatic breast cancer
On Sept. 25, 1998, the U.S. Food and Drug Administration (FDA) approved the monoclonal antibody Herceptin (Trastuzumab) for…
Biotechnology | Diagnostics | Life Science News | Oncology | Radiology | Therapeutics | Women's Health
Breast Cancer Prevention Trial Results published
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
The Stamp Out Breast Cancer stamp was first issued
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
The Seattle Cancer Care Alliance was formed
On Jun. 16, 1998, University of Washington Medicine, Fred Hutchinson Cancer Research Center and Seattle Children’s announced the…
The FDA approved Genentech drug Xeloda (capecitabine)
On April 30, 1998, the U.S. Food and Drug Administration (FDA) approved the Genentech’s drug Xeloda (capecitabine) for…
Seattle Genetics was incorporated
On Jan. 13, 1998, Seattle Genetics (Seagen) was founded in Bothell as a biotechnology company focused on developing…
The University of Minnesota Cancer Center was renamed the Masonic Cancer Center
In 1998, The University of Minnesota Cancer Center, which was founded in 1991, was renamed the Masonic Cancer…
The Prostate Centre at VGH was founded
In 1998, the The Prostate Centre at VGH, now known as the Vancouver Prostate Centre, was founded. The…
The City of Hope Cancer Center received NCI comprehensive cancer center designation
In 1998, National Cancer Institute (NCI) awarded the City of Hope Cancer Center NCI-comprehensive cancer center designation. City…
The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee
In 1998, The Norris Comprehensive Cancer Center received a $5 million gift from local philanthropist Henrietta Lee which…
Cancer incidence rates showed first sustained decline since NCI began keeping records in 1973
In 1998, Cancer incidence rates showed first sustained decline since the National Cancer Institute (NCI) began keeping records…
Biotechnology | Diagnostics | Disease | Life Science News | Medical Device | Oncology | Radiology | U.S. Congress | Women's Health
Mammography Quality Standards Reauthorization Act continued 1992 Act until 2002
In 1998, the Mammography Quality Standards Reauthorization Act (MQSA) was passed by the U.S. Congress and continued the…
Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some cancers
In 1998, Yale Cancer Center researchers discovered the gene, Survivin, which is linked to the detection of some…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, reduced the incidence of some breast cancer outcomes
In 1998, Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, was revealed to reduce…
The Case Cancer Center was recognized as an NCI-designated comprehensive cancer center
In 1998, The Case Cancer Center (Case CCC) was recognized as an National Cancer Institute (NCI)-designated comprehensive cancer…
The prevalence of U.S. adult smoking declined to 24.1 percent in 1998
In 1998, the Centers for Disease Control and Prevention (CDC) reported that an estimated 47.2 million adults (24.1%),…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
Monoclonal antibody rituximab (Rituxan) approved by the FDA to treat patients with non-Hodgkin lymphoma
On Nov. 26, 1997, the U.S. Food and Drug Administration (FDA) announced it had approved the Monoclonal antibody…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
The Stamp Out Breast Cancer Act (PL 105-41) was signed into law
On Aug. 13, 1997, the Stamp Out Breast Cancer Act (PL 105-41) was signed into law by President…
The NCI released information that nuclear testing during the 1950s could cause thyroid cancer
On Jul. 29, 1997, the National Cancer Institute (NCI) released information that nuclear testing during the 1950s could…
The National Cancer Institute created two new divisions through reorganization
On Jul. 23, 1997, Richard D. Klausner, M.D., director of the National Cancer Institute (NCI) announced the creation…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | U.S. Congress | Women's Health
the Art behind the Breast Cancer Research Postage Stamp
In August 1997, the U.S. Congress passed legislation that directed the U.S. Postal Service to issue its first…
The Cancer Genome Anatomy Project was launched
In 1997, the Cancer Genome Anatomy Project (CGAP), created by the National Cancer Institute (NCI), is a multi-year…
Biotechnology | Diagnostics | Disease | Environmental | Life Science News | NIH | Oncology
Scientists found that occupational exposure to benzene is associated with increased risks of developing acute non-lymphocytic leukemia
In 1997, the National Cancer Institute (NCI) and Chinese scientists found that occupational exposure to benzene is associated…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
The UCI Chao Family Comprehensive Cancer Center gained comprehensive cancer center status
In 1997, the the University of California, Irvine (UCI) Chao Family Comprehensive Cancer Center (CFCCC) gained NCI designated…
The University of Colorado Cancer Center received comprehensive cancer center designation from NCI
In 1997, the University of Colorado Cancer Center (CU) at the Anschutz Medical Campus received National Cancer Institute…
The Robert H. Lurie Comprehensive Cancer Center of Northwestern University received its NCI ‘comprehensive’ designation
In 1997, the Robert H. Lurie Comprehensive Cancer Center of Northwestern University received its National Cance Institute ‘comprehensive’…